サマリー

睡眠時無呼吸症候群用口腔内装置の世界市場は、2022年に推定7億米ドル、2027年には3億米ドルに達すると予測され、予測期間中に15.2%のCAGRで推移するとされています。市場の成長は、睡眠時無呼吸症候群の有病率の上昇や、CPAPに関連するコンプライアンス不良による代替治療オプションの需要増加といった要因によってもたらされます。カスタマイズされた口腔内装置や睡眠時無呼吸症候群の代替療法や投薬の価格が高いことが、この市場の成長を阻害する主な要因となっています。
"睡眠時無呼吸症候群の口腔内装置市場において、予測期間中、製品別では下顎前進装置セグメントが最も高い成長率を占めた"
睡眠時無呼吸症候群用口腔内装置市場は、製品に基づき、下顎前進装置（MAD）と舌保持装置（TRD）の2つの主要カテゴリに分類されます。2021年、睡眠時無呼吸症候群用口腔内装置市場では、下顎前進装置セグメントが最大のシェアを占めています。このセグメントの大きなシェアは、TRDsに対する有効性を裏付ける広範な研究とともに、その高い採用率に起因するものと考えられる。
「医師が処方/カスタマイズした口腔内装置分野が最も高いCAGRを占めた。
購入タイプに基づいて、睡眠時無呼吸症候群の口腔内装置市場は、-医師の処方/カスタマイズされた口腔内装置とオンラインOTC口腔内装置に区分されます。2021年の睡眠時無呼吸症候群用口腔内装置市場では、医師が処方/カスタマイズした口腔内装置セグメントが最大のシェアを占めています。このセグメントの成長を支える要因としては、不快感のレベルが低いこと、調整が容易であること、寿命が長いことなどが挙げられます。
"アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想される"
睡眠時無呼吸症候群用口腔内装置の世界市場は、北米、欧州、アジア太平洋地域、その他の地域の4つの主要地域に区分されています。アジア太平洋地域の睡眠時無呼吸症候群用口腔内装置市場は、患者数が多く、未診断の患者が多いことから、予測期間中に高い成長が見込まれており、アジア太平洋地域の睡眠時無呼吸症候群用装置市場の大きな潜在性を示しています。
本レポートで実施した主なインタビューは以下のように分類されます。

- 企業タイプ別企業タイプ別：Tier 1 - 40%、Tier 2 - 50%、Tier 3 - 10
- 役職別Cレベル：48％、Dレベル：37％、その他：15
- 地域別地域別：北米56％、欧州20％、アジア太平洋17％、その他の地域7
レポート掲載企業リスト

- SomnoMed（オーストラリア）
- ResMed（米国）
- ホール・ユー社（米国）
- プロソムナス・スリープ・テクノロジーズ（米国）
- ビボス・セラピューティック社（米国）
- Oventus Medical (オーストラリア)
- Panthera Dental (カナダ)
- エアウェイ・マネジメント（米国）
- アプネア・サイエンス社（米国）
- DynaFlex（米国）
- オラバンOSA (米国)
- マイヤーソンLLC (米国)
- MPowrx Health & Wellness (カナダ)
- ザ・スノア・リリーバー・カンパニー LLC (米国)
- ザ・ピュア・スリープ・カンパニー（米国）
- Tomed GmbH (ドイツ)
- オーラム・グループ（カナダ）
- Erkodent Erich Kopp GmbH (ドイツ)
- OSCIMED SA (スイス)
- SICAT GmbH & Co.Kg（ドイツ）
- グライドウェル社（米国）
- アプノメッド社（米国）
- ZYPPAH（米国）
- ドリームシステムズデンタルスリープラボラトリー(米国)
- SMLグローバルISOラボ（米国）

調査対象
本レポートは、世界の睡眠時無呼吸症候群用口腔内装置市場の詳細な情報を提供します。製品、購入タイプ、エンドユーザー、地域など、さまざまなセグメントにおける市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロファイル、最近の開発状況、主要な市場戦略とともに、詳細な競合分析も行っています。

レポート購入の主なメリット
本レポートは、睡眠時無呼吸症候群用口腔内装置市場全体とそのサブセグメントに関する収益数の最も近い近似値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争環境をより良く理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。

ページTOPに戻る

目次

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
TABLE 1 INCLUSIONS AND EXCLUSIONS 26
1.3 STUDY SCOPE 27
FIGURE 1 SLEEP APNEA ORAL APPLIANCES MARKET SCOPE 27
1.4 YEARS CONSIDERED 27
1.5 CURRENCY CONSIDERED 28
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 2 SLEEP APNEA ORAL APPLIANCES MARKET: RESEARCH DESIGN METHODOLOGY 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 32
2.1.2 PRIMARY DATA 33
FIGURE 3 PRIMARY SOURCES 33
2.1.3 KEY INDUSTRY INSIGHTS 34
2.1.3.1 Key data from primary sources 34
2.1.3.2 Breakdown of primary interviews 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36
2.2.1.2 Approach 2: Presentations of companies and primary interviews 36
2.2.1.3 Approach 3: Patient-based approach 37
FIGURE 6 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS 37
2.2.1.4 Growth forecast 38
2.2.1.5 CAGR projections 38
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
2.2.2 TOP-DOWN APPROACH 38
FIGURE 8 SLEEP APNEA ORAL APPLIANCES MARKET: TOP-DOWN APPROACH 39
2.3 DATA TRIANGULATION 40
FIGURE 9 DATA TRIANGULATION METHODOLOGY 40
2.4 RESEARCH ASSUMPTIONS 41
2.5 LIMITATIONS AND RISK ASSESSMENT 41
TABLE 2 RISK ASSESSMENT: SLEEP APNEA ORAL APPLIANCES MARKET 42
3 EXECUTIVE SUMMARY 43
FIGURE 10 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 43
FIGURE 11 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2022 VS. 2026 (USD MILLION) 44
FIGURE 12 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2022 VS. 2026 (USD MILLION) 44
FIGURE 13 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION,
2022 VS. 2026 (USD MILLION) 45
4 PREMIUM INSIGHTS 46
4.1 SLEEP APNEA ORAL APPLIANCES MARKET OVERVIEW 46
FIGURE 14 HIGH BURDEN OF SLEEP APNEA TO DRIVE MARKET GROWTH 46
4.2 SLEEP APNEA ORAL APPLIANCES MARKET, BY TECHNOLOGY (2022–2027) 47
FIGURE 15 MANDIBULAR ADVANCEMENT DEVICES TO REGISTER HIGHEST CAGR 47
4.3 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT AND COUNTRY (2021) 47
FIGURE 16 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SLEEP APNEA ORAL APPLIANCES MARKET IN 2021 47
4.4 SLEEP APNEA ORAL APPLIANCES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 17 ASIA PACIFIC MARKETS TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 18 SLEEP APNEA ORAL APPLIANCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 50
5.2.1.1 Large pool of undiagnosed sleep apnea patients 50
TABLE 3 PREVALENCE OF SLEEP APNEA IN 2019 50
TABLE 4 PREVALENCE OF SLEEP APNEA IN EUROPEAN COUNTRIES 51
5.2.1.2 Growing awareness of effects of untreated sleep apnea 51
TABLE 5 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA 52
5.2.1.3 Growing usage of oral appliances 52
TABLE 6 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA 53
5.2.2 RESTRAINTS 53
5.2.2.1 High prices of customized oral appliances 53
5.2.2.2 Alternative therapies and medications 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Growing demand for home sleep apnea tests 54
5.2.3.2 Increasing focus on telemedicine, mHealth, and AI 55
5.2.3.3 Poor compliance associated with CPAP 55
5.2.4 CHALLENGES 56
5.2.4.1 Complex referral pathways and long waiting periods 56
5.3 PRICING ANALYSIS 56
TABLE 7 AVERAGE SELLING PRICES OF SLEEP APNEA ORAL APPLIANCES 56
5.4 VALUE CHAIN ANALYSIS 57
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE 57
5.5 SUPPLY CHAIN ANALYSIS 58
FIGURE 20 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 58
5.6 PORTER’S FIVE FORCES ANALYSIS 59
5.6.1 THREAT OF NEW ENTRANTS 59
5.6.2 THREAT OF SUBSTITUTES 59
5.6.3 BARGAINING POWER OF SUPPLIERS 59
5.6.4 BARGAINING POWER OF BUYERS 59
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.7 ECOSYSTEM ANALYSIS 60
FIGURE 21 SLEEP APNEA ORAL APPLIANCES MARKET: ECOSYSTEM ANALYSIS 60
5.7.1 ROLE IN ECOSYSTEM 60
FIGURE 22 KEY PLAYERS IN SLEEP APNEA ORAL APPLIANCES MARKET ECOSYSTEM 61
5.8 REGULATORY ANALYSIS 61
TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING SLEEP APNEA ORAL APPLIANCES 61
5.8.1 NORTH AMERICA 62
5.8.1.1 US 62
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 63
5.8.1.1.1 Reimbursement scenario 63
5.8.1.2 Canada 64
TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 64
5.8.2 EUROPE 64
5.8.3 ASIA PACIFIC 65
5.8.3.1 Japan 65
TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 65
5.8.3.2 China 66
TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 66
5.8.3.3 India 67
5.8.3.4 Australia 67
5.9 PATENT ANALYSIS 68
5.9.1 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES 68
FIGURE 23 PATENT TRENDS FOR SLEEP APNEA ORAL APPLIANCES,
JANUARY 2011–JULY 2022 68
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 69
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR SLEEP APNEA ORAL APPLIANCE PATENTS, JANUARY 2011—JUNE 2022 69
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.10.1 REVENUE SHIFT & REVENUE POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS 70
FIGURE 25 REVENUE SHIFT FOR SLEEP APNEA ORAL APPLIANCES 70
5.11 KEY CONFERENCES & EVENTS IN 2022–2023 71
TABLE 13 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF CONFERENCES & EVENTS 71
5.12 TECHNOLOGY ANALYSIS 72
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 73
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES 73
TABLE 14 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF SLEEP APNEA ORAL APPLIANCES (%) 73
5.13.2 BUYING CRITERIA 74
FIGURE 27 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 74
TABLE 15 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA ORAL APPLIANCES 74
5.14 TRADE ANALYSIS 75
TABLE 16 IMPORT DATA FOR HS CODE 901849, BY COUNTRY,
2017–2021 (USD MILLION) 75
TABLE 17 EXPORT DATA FOR HS CODE 901849, BY COUNTRY,
2017–2021 (USD MILLION) 75
6 END-USER PERCEPTION ANALYSIS 76
6.1 BENEFITS AND LIMITATIONS OF CURRENT PRODUCT TYPES 76
6.2 BUYING DECISION-MAKING PROCESS 77
6.2.1 INTRODUCTION 77
6.2.2 NEED RECOGNITION 77
6.2.3 GATHERING INFORMATION 77
6.2.4 EVALUATING ALTERNATIVES 78
6.2.5 NEED-GAP ANALYSIS 79
7 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA 80
7.1 INTRODUCTION 80
7.2 EPIDEMIOLOGICAL ASSESSMENT 80
FIGURE 28 TOP TEN COUNTRIES WITH HIGHEST ESTIMATED NUMBER OF INDIVIDUALS SUFFERING FROM OSA 81
7.3 PRESCRIPTION PATTERN ASSESSMENTS 82
7.4 ADHERENCE ASSESSMENT 83
 
8 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT 85
8.1 INTRODUCTION 86
TABLE 18 SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 86
8.2 MANDIBULAR ADVANCEMENT DEVICES 86
TABLE 19 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 87
TABLE 20 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 87
8.2.1 READY-MADE MANDIBULAR ADVANCEMENT DEVICES 87
8.2.1.1 Low costs drive demand for ready-made MADs 87
TABLE 21 READY-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 88
8.2.2 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES 88
8.2.2.1 Increasing efficacy of custom-made MADs to drive market growth 88
TABLE 22 CUSTOM-MADE MANDIBULAR ADVANCEMENT DEVICES MARKET,
BY REGION, 2020–2027 (USD MILLION) 88
8.3 TONGUE-RETAINING DEVICES 89
8.3.1 LOWER DEVICE SUCCESS RATE TO CHALLENGE MARKET GROWTH 89
TABLE 23 TONGUE-RETAINING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 89
9 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE 90
9.1 INTRODUCTION 91
TABLE 24 SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2020–2027 (USD MILLION) 91
9.2 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES 91
9.2.1 FAILURE OF CPAP THERAPY INDICATES OPPORTUNITIES FOR PHYSICIAN-PRESCRIBED ORAL APPLIANCES 91
TABLE 25 PHYSICIAN-PRESCRIBED/CUSTOMIZED ORAL APPLIANCES MARKET,
BY REGION, 2020–2027 (USD MILLION) 92
9.3 ONLINE OTC ORAL APPLIANCES 92
9.3.1 LACK OF REGULATORY APPROVAL TO HINDER MARKET GROWTH FOR ONLINE OTC ORAL APPLIANCES 92
TABLE 26 ONLINE OTC ORAL APPLIANCES MARKET, BY REGION,
2020–2027 (USD MILLION) 93
10 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER 94
10.1 INTRODUCTION 95
TABLE 27 SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 95
10.2 HOME CARE SETTINGS/INDIVIDUALS 95
10.2.1 RISING PATIENT PREFERENCE FOR ADVANCED HOME SLEEP CARE DEVICES TO DRIVE MARKET 95
TABLE 28 HOME CARE SETTINGS/INDIVIDUALS MARKET, BY REGION,
2020–2027 (USD MILLION) 95
10.3 HOSPITALS 96
10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE DEMAND FOR ORAL APPLIANCES IN HOSPITALS 96
TABLE 29 HOSPITALS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
10.4 DENTAL CLINICS 97
10.4.1 RISING NUMBER OF DENTAL CLINICS TO BOOST MARKET GROWTH 97
TABLE 30 DENTAL CLINICS MARKET, BY REGION, 2020–2027 (USD MILLION) 97
11 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION 98
11.1 INTRODUCTION 99
TABLE 31 SLEEP APNEA ORAL APPLIANCES MARKET, BY REGION,
2020–2027 (USD MILLION) 99
11.2 NORTH AMERICA 99
FIGURE 29 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 100
TABLE 32 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 33 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101
TABLE 34 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 35 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PURCHASE TYPE, 2020–2027 (USD MILLION) 102
TABLE 36 NORTH AMERICA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2020–2027 (USD MILLION) 102
11.2.1 US 102
11.2.1.1 US to dominate North American market 102
TABLE 37 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 103
TABLE 38 US: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
TABLE 39 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2020–2027 (USD MILLION) 104
TABLE 40 US: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 104
11.2.2 CANADA 104
11.2.2.1 Large pool of undiagnosed patients to drive market growth 104
TABLE 41 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 105
TABLE 42 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 105
TABLE 43 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 106
TABLE 44 CANADA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 106
 
11.3 EUROPE 107
TABLE 45 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 107
TABLE 46 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 107
TABLE 47 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 108
TABLE 48 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 108
TABLE 49 EUROPE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 108
11.3.1 GERMANY 109
11.3.1.1 Germany dominates European sleep apnea oral appliances market 109
TABLE 50 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 109
TABLE 51 GERMANY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 110
TABLE 52 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 110
TABLE 53 GERMANY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 110
11.3.2 FRANCE 111
11.3.2.1 Rising aging population in France to increase patient pool for OSA and drive market growth 111
TABLE 54 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 111
TABLE 55 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 112
TABLE 56 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 112
TABLE 57 FRANCE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 112
11.3.3 UK 113
11.3.3.1 Sleep apnea management and awareness in UK to propel market growth 113
TABLE 58 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 113
TABLE 59 UK: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
TABLE 60 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2020–2027 (USD MILLION) 114
TABLE 61 UK: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 114
11.3.4 ITALY 115
11.3.4.1 Growing sleep disorder patient population to drive demand for oral appliances in Italy 115
TABLE 62 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 115
TABLE 63 ITALY: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 115
TABLE 64 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 116
TABLE 65 ITALY: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 116
11.3.5 SPAIN 116
11.3.5.1 Low social awareness about sleep apnea and treatment options is challenging growth for oral appliances in Spain 116
TABLE 66 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 117
TABLE 67 SPAIN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 68 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 117
TABLE 69 SPAIN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 118
11.3.6 REST OF EUROPE 118
TABLE 70 ROE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 118
TABLE 71 ROE: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 119
TABLE 72 ROE: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2020–2027 (USD MILLION) 119
TABLE 73 ROE: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 119
11.4 ASIA PACIFIC 120
FIGURE 30 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET SNAPSHOT 120
TABLE 74 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 75 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121
TABLE 76 ASIA PACIFIC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 77 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET,
BY PURCHASE TYPE, 2020–2027 (USD MILLION) 122
TABLE 78 ASIA PACIFIC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER, 2020–2027 (USD MILLION) 122
11.4.1 JAPAN 122
11.4.1.1 Poor reimbursement to restrain market growth 122
TABLE 79 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 123
TABLE 80 JAPAN: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 81 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 124
TABLE 82 JAPAN: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 124
11.4.2 CHINA 124
11.4.2.1 Increasing diagnostics market in China to raise demand for appliances 124
TABLE 83 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 125
TABLE 84 CHINA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 125
TABLE 85 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 126
TABLE 86 CHINA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 126
11.4.3 AUSTRALIA 126
11.4.3.1 Rising number of domestic manufacturers of oral appliances to drive demand in Australia 126
TABLE 87 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 127
TABLE 88 AUSTRALIA: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 89 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 127
TABLE 90 AUSTRALIA: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 128
11.4.4 REST OF ASIA PACIFIC 128
TABLE 91 ROAPAC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 129
TABLE 92 ROAPAC: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 129
TABLE 93 ROAPAC: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE, 2020–2027 (USD MILLION) 129
TABLE 94 ROAPAC: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 130
11.5 REST OF THE WORLD 130
TABLE 95 ROW: SLEEP APNEA ORAL APPLIANCES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 130
TABLE 96 ROW: MANDIBULAR ADVANCEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 131
TABLE 97 ROW: SLEEP APNEA ORAL APPLIANCES MARKET, BY PURCHASE TYPE,
2020–2027 (USD MILLION) 131
TABLE 98 ROW: SLEEP APNEA ORAL APPLIANCES MARKET, BY END USER,
2020–2027 (USD MILLION) 131
12 COMPETITIVE LANDSCAPE 132
12.1 OVERVIEW 132
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 132
TABLE 99 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 132
12.3 REVENUE ANALYSIS 133
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS 133
12.4 MARKET SHARE ANALYSIS 134
TABLE 100 SLEEP APNEA ORAL APPLIANCES MARKET: DEGREE OF COMPETITION 134
FIGURE 32 MARKET SHARE ANALYSIS, 2021 135
12.5 COMPANY EVALUATION MATRIX 136
12.5.1 STARS 136
12.5.2 EMERGING LEADERS 136
12.5.3 PERVASIVE PLAYERS 136
12.5.4 PARTICIPANTS 136
FIGURE 33 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION QUADRANT 137
12.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS) 138
12.6.1 PROGRESSIVE COMPANIES 138
12.6.2 STARTING BLOCKS 138
12.6.3 RESPONSIVE COMPANIES 138
12.6.4 DYNAMIC COMPANIES 138
FIGURE 34 SLEEP APNEA ORAL APPLIANCES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 139
12.7 COMPANY FOOTPRINT ANALYSIS 140
TABLE 101 COMPANY FOOTPRINT 140
TABLE 102 COMPANY PRODUCT FOOTPRINT 141
TABLE 103 COMPANY REGIONAL FOOTPRINT 142
12.8 COMPETITIVE BENCHMARKING 143
TABLE 104 SLEEP APNEA ORAL APPLIANCES MARKET: DETAILED LIST OF KEY START-UPS/SMES 143
12.9 COMPETITIVE SCENARIO 143
12.9.1 PRODUCT LAUNCHES & APPROVALS 143
TABLE 105 SLEEP APNEA ORAL APPLIANCES MARKET: PRODUCT LAUNCHES & APPROVALS, 2019–2022 143
12.9.2 DEALS 144
TABLE 106 SLEEP APNEA ORAL APPLIANCES MARKET: DEALS, 2019–2022 144
12.9.3 OTHER DEVELOPMENTS 144
TABLE 107 SLEEP APNEA ORAL APPLIANCES MARKET: OTHER DEVELOPMENTS, 2019–2022 144
13 COMPANY PROFILES 146
13.1 KEY PLAYERS 146
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 SOMNOMED 146
TABLE 108 SOMNOMED: BUSINESS OVERVIEW 146
FIGURE 35 SOMNOMED: COMPANY SNAPSHOT (2021) 147
13.1.2 RESMED 149
TABLE 109 RESMED: BUSINESS OVERVIEW 149
FIGURE 36 RESMED: COMPANY SNAPSHOT (2021) 150
13.1.3 WHOLE YOU 153
TABLE 110 WHOLE YOU: BUSINESS OVERVIEW 153
13.1.4 PROSOMNUS SLEEP TECHNOLOGIES 155
TABLE 111 PROSOMNUS SLEEP TECHNOLOGIES: BUSINESS OVERVIEW 155
FIGURE 37 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2021) 155
13.1.5 VIVOS THERAPEUTICS 157
TABLE 112 VIVOS THERAPEUTICS: BUSINESS OVERVIEW 157
FIGURE 38 VIVOS THERAPEUTICS: COMPANY SNAPSHOT (2021) 157
13.1.6 OVENTUS MEDICAL 159
TABLE 113 OVENTUS MEDICAL: BUSINESS OVERVIEW 159
FIGURE 39 OVENTUS MEDICAL: COMPANY SNAPSHOT (2021) 160
13.1.7 PANTHERA DENTAL 162
TABLE 114 PANTHERA DENTAL: BUSINESS OVERVIEW 162
13.1.8 AIRWAY MANAGEMENT 164
TABLE 115 AIRWAY MANAGEMENT: BUSINESS OVERVIEW 164
13.1.9 APNEA SCIENCES 165
TABLE 116 APNEA SCIENCES: BUSINESS OVERVIEW 165
13.1.10 DYNAFLEX 166
TABLE 117 DYNAFLEX: BUSINESS OVERVIEW 166
13.1.11 ORAVANOSA 167
TABLE 118 ORAVANOSA: BUSINESS OVERVIEW 167
13.1.12 MYERSON LLC 168
TABLE 119 MYERSON LLC: BUSINESS OVERVIEW 168
13.2 OTHER PLAYERS 169
13.2.1 MPOWRX HEALTH & WELLNESS 169
13.2.2 THE SNORE RELIEVER COMPANY, LLC 169
13.2.3 THE PURE SLEEP COMPANY 170
13.2.4 TOMED GMBH 170
13.2.5 THE AURUM GROUP 171
13.2.6 ERKODENT ERICH KOPP GMBH 171
13.2.7 OSCIMED SA 172
13.2.8 SICAT GMBH & CO. KG 172
13.2.9 GLIDEWELL 173
13.2.10 APNOMED 173
13.2.11 ZYPPAH 174
13.2.12 DREAM SYSTEMS DENTAL SLEEP LABORATORY 174
13.2.13 SML GLOBAL ISO LAB 175
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
14 APPENDIX 176
14.1 DISCUSSION GUIDE 176
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 179
14.3 AVAILABLE CUSTOMIZATION OPTIONS 181
14.4 RELATED REPORTS 181
14.5 AUTHOR DETAILS 182